GLP-1 drugs could reduce long-term sick leave: Study

(NewsNation) — Popular weight loss drugs could benefit the economy by reducing sick time, according to new research.

An economic study published this month found that GLP-1 medications, which include Ozempic and Wegovy, resulted in employees taking 17 percent less long-term sick leave.

The study, published by the National Bureau of Economic Research, defined “long-term” as absences of more than 30 days related to illness and used Danish data to examine the connection between the drugs and absences.

Originally developed as diabetes drugs, GLP-1s have soared in popularity when used........

© The Hill